|
EBS Emergent Biosolutions Inc 1367644 |
| Balance Sheet |
|
Current Assets
|
$666,000,000.00 |
|
Assets
|
$1,116,800,000.00 |
|
Current Liabilities
|
$122,800,000.00 |
|
Liabilities
|
$775,400,000.00 |
|
Equity
|
$341,400,000.00 |
|
Shares Out
|
51300000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$22,300,000.00 |
|
Investing Cash Flow
|
$-54,700,000.00 |
| Market Analysis |
Market Cap
|
$247,266,000.00 |
|
Price
|
$6.80 |
|
BVPS
|
6.66 |
|
PB
|
0.72 |
|
EPS
|
-3.49 |
|
PS
|
0.26 |
|
FCF
|
$17,800,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.43 |
|
| Apr |
May |
Jun |
|
|
2026-04-30 |
0.21 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.16 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
1.06 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EBS documents filed with the SEC.
EBS Filings
Clear
